
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Anesthesia providers should be aware of perioperative complications that are more likely to occur with children who are obese, including major oxygen desaturation and critical airway events, according to research published in the March issue of Anesthesiology.






